1-2 of 2
Jason T. Romancik
Close
Sort by
Journal Articles

Efficacy of checkpoint inhibition after CAR-T failure in aggressive B-cell lymphomas: outcomes from 15 US institutions

Ajay Major, Jovian Yu, Navika Shukla, Yan Che, Theodore G. Karrison, Rachel Treitman, Manali K. Kamdar, Bradley M. Haverkos, James Godfrey, Melissa A. Babcook, Timothy J. Voorhees, Sophie Carlson, Daria Gaut, Caspian Oliai, Jason T. Romancik, Allison M. Winter, Brian T. Hill, Radhika Bansal, Jose C. Villasboas Bisneto, Imran A. Nizamuddin, Reem Karmali, Lindsey A. Fitzgerald, Deborah M. Stephens, Priyanka A. Pophali, Asaad Trabolsi, Jonathan H. Schatz, Marie Hu, Veronika Bachanova, Michael J. Slade, Nathan Singh, Nausheen Ahmed, Joseph P. McGuirk, Michael R. Bishop, Peter A. Riedell, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4528–4538.
https://doi.org/10.1182/bloodadvances.2023010016
Published: 2023
Includes: Supplemental data
Journal Articles

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma

Yazeed Sawalha, Subir Goyal, Jeffrey M. Switchenko, Jason T. Romancik, Manali Kamdar, I. Brian Greenwell, Brian T. Hess, Krista M. Isaac, Craig A. Portell, Alex Mejia Garcia, Scott Goldsmith, Natalie S. Grover, Peter A. Riedell, Reem Karmali, Madelyn Burkart, Michael Buege, Othman Akhtar, Pallawi Torka, Anita Kumar, Brian T. Hill, Brad S. Kahl, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (13): 2983–2993.
https://doi.org/10.1182/bloodadvances.2022008916
Published: 2023
Includes: Supplemental data